Enclomiphene (Androxal)
Unapproved testosterone-boosting compound: a cleaner version of Clomid, developed for low hormone levels in men.

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Related comparisons
Nolvadex vs Clomid vs EnclomipheneDETAILED OVERVIEW
What is Enclomiphene (Androxal)?
Enclomiphene (Androxal) is one of the two components of the medicine Clomid: it lacks the other one, which causes Clomid's mood side effects. It was developed for low testosterone in men but has never been approved as a medicine: the US authority asked for further data in 2016, and the developing company never resubmitted its application. After stopping steroids, it is also used to restart the body's own hormone production.
It blocks the estrogen signal in the pituitary gland, so the gland produces more of the hormones that stimulate the testicles. In studies this raised testosterone while sperm production was preserved, but its long-term safety has not been proven. Side effects can include vision problems, headache, mood swings and, rarely, breast growth, and with this type of hormone modulator the risk of blood clots also rises. It must not be used in pregnancy, and in competitive sport it is banned both in and out of competition.
Mechanism
Estrogen receptor blocker; without the mood-disturbing form of clomiphene
Half-life
~5 days (cleaner than Clomid mixed t1/2)
Onset
LH rise 24-72 h, Test recovery 2-4 weeks
Legal status
NOT FDA-approved (CRL 2016), US-compounding + EU research-pharm + UGL
Enclomiphene is described in anecdotal reports as a solid option for users seeking to enhance endogenous testosterone production. It is generally not positioned as a replacement for AAS, but it has a defined niche. Compared to Clomiphene, Enclomiphene is the 'cleaner' isomer – providing the testosterone-boosting effect without much of the emotional or vision-related side effects associated with Clomid (which contains the zuclomiphene isomer). Users typically report better energy, increased libido, better mood, and other testosterone-related effects. It does not meaningfully suppress endogenous production, but its efficacy depends on a functional HPTA – it enhances rather than replaces. In heavily suppressed users, it may take time to work or be less effective than HCG. Overall, community accounts consider it one of the more favorable options for raising testosterone naturally without inducing shutdown. Administered orally; protocols are adjusted based on bloodwork and symptoms.
⚠ Not clinical evidence – based on user accounts.
Data console
Lab data
Wiehle RD, Fontenot GK, Wike J, Hsu K, Nieschlag E, Saadabadi A . Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone.. Fertil Steril.
Kim ED, McCullough A, Kaminetsky J . Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement.. BJU Int.
Kaminetsky J, Werner M, Fontenot G, Wiehle RD . Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel.. J Sex Med.
Rahnema CD, Lipshultz LI, Crosnoe LE, Kovac JR, Kim ED . Anabolic steroid-induced hypogonadism: diagnosis and treatment.. Fertil Steril.
Safety
Side effects, stop signs, contraindications
Side effects · 7
- Visual disturbances: blurred vision, light flashes (photopsia), glare. A known SERM-class effect from retinal ER modulation – rarer and milder than with Clomid, but persistent symptoms warrant immediate discontinuation.
- Elevated estradiol (E2): the increased LH raises testicular testosterone and, via aromatization, can raise E2, presenting as water retention, mood swings and rarely gynecomastia.
- Headache: the most commonly reported adverse event in the Phase III trials, usually mild and transient.
- Mood swings, irritability: markedly rarer and milder than with Clomid (the zuclomiphene isomer is absent), but not fully eliminated – emotional lability and irritability can occur.
- Nausea and gastrointestinal discomfort: GI upset can occur and is reduced by taking the dose with a morning meal.
- Venous thromboembolism risk: estrogen-receptor modulation carries a prothrombotic effect across the SERM class; deep vein thrombosis and pulmonary embolism risk exists, especially with predisposing factors.
- Unknown long-term safety profile: the FDA Complete Response Letter (2016) was issued precisely over missing long-term cardiovascular, bone and prostate data; chronic use (>3 months) safety is unproven.
Contraindications · 6
- Pregnancy and teratogenicity: clomiphene compounds are contraindicated in pregnancy (Pregnancy Category X); heightened caution is needed if a female partner could conceive. Risk of fetal harm in women.
- Prior or active thromboembolism: avoid in deep vein thrombosis, pulmonary embolism, stroke history or known thrombophilia due to the prothrombotic effect of SERMs.
- Active or severe liver disease: a relative contraindication in active hepatic dysfunction due to hepatic metabolism; liver function monitoring required.
- Hormone-sensitive tumor: avoid in estrogen- or androgen-dependent tumors (e.g. prostate cancer) or undiagnosed abnormal genital bleeding.
- Primary (hypergonadotropic) hypogonadism: efficacy depends on an intact HPTA and functioning testes; it is ineffective and not indicated in primary testicular failure (high LH/FSH).
- Competitive athletes: listed on the WADA S4 prohibited list (hormone and metabolic modulators, SERMs), banned in and out of competition for men.
Related Performance Compounds
Same therapeutic category
Studies
Related research and clinical findings
Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone.
Wiehle RD, Fontenot GK, Wike J, Hsu K, Nieschlag E, Saadabadi A
Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement.
Kim ED, McCullough A, Kaminetsky J
Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel.
Kaminetsky J, Werner M, Fontenot G, Wiehle RD
Anabolic steroid-induced hypogonadism: diagnosis and treatment.
Rahnema CD, Lipshultz LI, Crosnoe LE, Kovac JR, Kim ED
Telegram
Have a question about Enclomiphene (Androxal)?
Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.